Relationship between the expression of phospho-Akt level in breast cancers and clinical biology factors tissues

Su-ping CUI,Jing ZHAO,Xiu-hua YIN,Ping JIANG,Hai-jing LIU,Lin HOU,Bo ZHANG
DOI: https://doi.org/10.16073/j.cnki.cjcpt.2011.17.004
2011-01-01
Abstract:OBJECTIVE: To investigate the relationship between phosphorylated Akt (pAkt) and the clinical marker such as HER-2 (human epidermal growth receptor-2), ER (estrogen receptor), PR (progesterone receptor), p53, Ki-67 in breast cancer. METHODS: The expression of pAkt, HER-2, ER, PR, p53, and Ki-67 of sixteen cases of ductal carcinoma in situ (DCIS) and 70 cases of invasive ductal carcinoma (IDC) in breast were detected by immunohistochemistry. Their correlations with the expression level of pAkt were statistically analyzed. RESULTS: The level of pAkt was significantly different between DCIS and IDC [0(0/16) vs 38.6% (27/70), P = 0.003]. The level of pAkt was closely correlated with HER-2 expression level in 70 cases of IDC, the level of pAkt gradually increased following HER-2 [P = 0.000, negative group (18.8%, 6/32); Her-2 not sure group (37.5%, 6/16); Her-2 positive group (68.2%, 15/22)]. Besides, the expression of pAkt was significantly increased in group with lymph node metastasis (P = 0.009). CONCLUSIONS: The phosphorylated Akt should be involved in the invasive transition in cancer and positively correlated the over-expression of HER-2. In addition, the high level of pAkt indicates earlier matastasis in the progress of breast cancers.
What problem does this paper attempt to address?